ANI Pharma (ANIP) Announces Proposed Stock Offering, Size not Disclosed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
ANI Pharma (ANIP) Prices 1.5M Share IPO at $50/sh
November 4, 2021 5:36 AM EDTANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today announced the pricing of an underwritten public offering of 1,500,000 shares of its common stock at a public offering price of $50.00 per share. The gross proceeds of the offering to the Company are expected to be $75 million, before deducting the underwriting discounts and commissions and other offering expenses. In addition, ANI granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
The... More
Truist Securities Starts ANI Pharmaceuticals (ANIP) at Buy
November 2, 2021 6:06 AM EDTTruist Securities analyst Gregory Fraser initiates coverage on ANI Pharmaceuticals (NASDAQ: ANIP) with a Buy rating and a price target of $70.00.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $55.89 yesterday.
... MorePre-Open Stock Movers 11/01: (ANIP) (LDI) (HOG) Higher; (BTBT) (TRIP) (CRWD) Lower (more...)
November 1, 2021 9:29 AM EDTPre-Open Stock Movers:
Bit Digital, Inc. (NASDAQ: BTBT) 17% LOWER; gives back some of Friday's late-day surge.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) 15.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved the Companys supplemental New Drug Application (sNDA) for Purified Cortrophin Gel (Repository Corticotropin Injection USP) (Cortrophin Gel) for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis (MS) and rheumatoid arthritis (RA), in addition to excess urinary protein due... More
ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh
November 1, 2021 6:48 AM EDTANI Pharma (NASDAQ: ANIP) reported Q3 EPS of ($0.37), versus $0.04 reported last year. Revenue for the quarter came in at $52.1 million, versus $52.98 million reported last year.
For earnings history and earnings-related data on ANI Pharma (ANIP) click here.
... More